Search Within

Andrea Cercek Hanjis

Formats
  1. Meeting Abstract (161)
  2. Journal Article (151)
  3. Editorial (11)
  4. Review (9)
  5. Correspondence (6)
  6. Miscellaneous (6)
  7. Research Letter (3)
  8. Book Section (2)
  9. Guidelines (2)
Groups
  1. Department of Medicine (351)
  2. Gastrointestinal Oncology Service (351)
  3. Solid Tumor Oncology Division (351)
  4. Survivorship Research (351)
  5. Center for Pancreatic Cancer Research (235)
  6. Surgery (227)

More Groups

People
  1. Leonard Saltz (124)
  2. Nancy Kemeny (104)
  3. Martin Weiser (96)
  4. Rona Yaeger (93)
  5. Julio Garcia Aguilar (87)
  6. Michael D'Angelica (81)

More People

Years
  1. 2025 (20)
  2. 2024 (48)
  3. 2023 (49)
  4. 2022 (37)
  5. 2021 (33)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (112)
  2. Annals of Surgical Oncology (39)
  3. Annals of Oncology (20)
  4. Clinical Cancer Research (15)
  5. International Journal of Radiation Oncology, Biology, Physics (10)
  6. Clinical Colorectal Cancer (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (120)
  2. Springer (53)
  3. Elsevier Inc. (33)
  4. Oxford University Press (29)
  5. American Association for Cancer Research (23)
  6. Wiley Blackwell (15)

More Publishers

Results (351)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC
    Meeting Abstract

    Strickler, J. H.; Cercek, A.; Siena, S.; Andre, T.; Ng, K.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J.; Coveler, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Pharmaceutical agents as potential drivers in development of early-onset colorectal cancer (EOCRC)
    Meeting Abstract

    Ben-Aharon, I.; Rotem, R.; Cercek, A.; Half, E.; Goshen-Lago, T. G.; Chodick, G.; Kelsen, D. P.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER
    Meeting Abstract

    Wu, C.; Strickler, J. H.; Cercek, A.; Siena, S.; André, T.; Ng, K.; Van Cutsem, E.; Paulson, A. S.; Hubbard, J.; Coveler, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Considerations and barriers to starting a new HAI pump program: An international survey of the HAI Consortium Research Network
    Journal Article

    Cavnar, M.; Ghalambor, T.; Lidsky, M. E.; Dominguez-Rosado, I.; Cho, M.; Karanicolas, P.; Merkow, R.; Mayo, S. C.; Rocha, F. G.; Fields, R. C.; more...
    HPB (2022)

    Fulltext@MSK | Save
  • Clinical features of young onset colorectal cancer patients from a large cohort at a single cancer center
    Journal Article

    Park, L.; O’Connell, K.; Herzog, K.; Chatila, W.; Walch, H.; Palmaira, R. L. D.; Cercek, A.; Shia, J.; Shike, M.; Markowitz, A. J.; more...
    International Journal of Colorectal Disease (2022)

    Fulltext@MSK | Save
  • Clinical activity of pembrolizumab monotherapy in diffuse malignant peritoneal mesothelioma
    Meeting Abstract

    Wang, X.; Offin, M.; Roshkovan, L.; Miura, J.; Ginsberg, M. S.; Ciunci, C. A.; Egger, J. V.; Walker, S.; Cercek, A.; Litzky, L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1b study of RGX-202-01, a first-in-class oral inhibitor of the SLC6A8/CKB pathway, in combination with FOLFIRI and bevacizumab (BEV) in second-line advanced colorectal cancer (CRC)
    Meeting Abstract

    Hendifar, A. E.; Rosen, L. S.; Cercek, A.; McRee, A. J.; Mallick, A. B.; Spigel, D. R.; Tavazoie, S. F.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade
    Meeting Abstract

    Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)
    Meeting Abstract

    Harrold, E.; Solter, M.; Walch, H. S.; Chatila, W. K.; Keane, F.; Lumish, M. A.; Yaeger, R.; Weiss, J. A.; Palmaira, R. L.; Krishnan, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save